|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City | 515 N. STATE STREET, CHICAGO |
State | IL |
Zip Code | 60654 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
TYPE OF REPORT | 8. Year | 2013 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: George E. Cox III |
Date | 07/18/2013 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 1960, House National Defense Authorization Act for FY2014, provisions relating to Medicare, TRICARE and Veterans Affairs
health plans
S. 1034, Senate National Defense Authorization Act for FY2014, provisions relating to Medicare, TRICARE and Veterans Affairs
health plans
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 1180, Resident Physician Shortage Reduction Act of 2013, provisions relating to GME funding
S. 577, Resident Physician Shortage Reduction Act of 2013, provisions relating to GME funding
Graduate Medical Education
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S. 649, Safe Communities, Safe Schools Act of 2013, all provisions
S. 150, Assault Weapons Ban of 2013, all provisions
S. 160, Medical Debt Responsibility Act of 2013, all provisions
H.R. 1701, Cutting Costly Codes Act of 2013, all provisions
S. 972, Cutting Costly Codes Act of 2013, all provisions
H.R. 2415, Treat and Reduce Obesity Act of 2013, all provisions
H.R. 1416, Cancer Patient Protection Act of 2013, all provisions
H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013, all provisions
H.R. 1427, Truth in Healthcare Marketing Act of 2013, all provisions
S. 539, National Diabetes Clinical Care Commission Act, all provisions
H.R. 1915, Gestational Diabetes (GEDI) Act, all provisions
S. 907, Gestational Diabetes (GEDI) Act, all provisions
Affordable Care Act (ACA) - repeal of Section 9003, FSA/HSA over-the-counter prescription requirement
ACA - Repeal Section 2706(a)
ACA Implementation Issues
Forced feeding of detainees in U.S. custody
Quality Measure Development
Electronic Health Records - Meaningful Use Regulations
In-Office Ancillary Services Exception
Prescription Drug Diversion and Abuse
Pain Management
Prescriber Education and CME Training
Drug Shortages
Mental Health Issues
Diabetes Commission
Hypertension and Diabetes
Compounding
Telehealth
Health Insurance Reform
Improving health outcomes
Gun violence
HIPAA
Diversion of funds from HHS Prevention Fund
Exchanges
Emergency Contraception
Hospital Medical Staff
Hospital Acquired Conditions
Hospital Quality Reporting
Sunshine
Million Hearts
CMMI and Y Program
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Defense - Dept of (DOD), Agency for Health Care Policy & Research, Food & Drug Administration (FDA), President of the U.S., Government Accountability Office (GAO)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Margaret |
Garikes |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Jennifer |
Meeks |
|
|
|
Mari |
Savickis |
|
|
|
Carol |
Vargo |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Cybil |
Roehrenbeck |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
S. 616, Conrad State 30 and Physician Access Act, all provisions
S. 744, Border Security, Economic Opportunity, and Immigration Modernization Act, provisions relating to H-1B Visa
H.R. 2131, SKILLS Visa Act, all provisions
J-1 and H-1B Visa
Medical Licensing Boards and Scope of Practice
Health Care Market Competition
Shared Savings/Accountable Care Organization program
DOJ-FTC Health Care Antitrust Guidelines
Physician employment risks in the United Arab Emirates (UAE)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, Federal Trade Commission (FTC), U.S. HOUSE OF REPRESENTATIVES, Justice - Dept of (DOJ), State - Dept of (DOS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Margaret |
Garikes |
|
|
|
Carol |
Vargo |
|
|
|
George |
Cox |
III |
|
|
Cybil |
Roehrenbeck |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 1310, Medicare Patient Empowerment Act of 2013, all provisions
S. 236, Medicare Patient Empowerment Act, all provisions
H.R. 351, Protecting Seniors' Access to Medicare Act of 2013, all provisions
S. 351, Protecting Seniors' Access to Medicare Act of 2013, all provisions
S. 1180, Medicare Data Access for Transparency and Accountability Act, all provisions
H.R. 1701, Cutting Costly Codes Act of 2013, all provisions
S. 972, Cutting Costly Codes Act of 2013, all provisions
H.R. 1761, Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians Act (HELLPP Act), all provisions
H.R. 846, Diagnostic Imaging Services Access Protection Act of 2013, all provisions
H.R. 1179, Improving Access to Medicare Coverage Act of 2013, all provisions
S. 569, Improving Access to Medicare Coverage Act of 2013, all provisions
H.R. 1331, Electronic Health Records Improvement Act, all provisions
H.R. 962, Medicare Diabetes Prevention Act of 2013, all provisions
S. 452, Medicare Diabetes Prevention Act of 2013, all provisions
The Medicare Payment Stability and Premium Security Act ( Draft bill)
Medicare program - Sustainable Growth Rate (SGR) Repeal
Medicare program - Physician Payment Reform
Medicare program - Sequestration
Medicare program - In-Office Ancillary Services Exception
Medicare program - Independent Payment Advisory Board (IPAB) Repeal
Medicare program - New payment models/measuring quality performance
Medicare program - Payment and Delivery Reform
Medicare program - Medicare Private Contracting
Medicare program - Electronic Health Records/Meaningful Use Regulations
Medicare program - Graduate Medical Education
Medicare program - Claims Data
Medicare program - ICD-10 Repeal
Medicare program - Recovery Audit Contractors
Medicare program - Clinical Lab Fee Schedule
Medicare program - Quality Reporting Programs
Medicare program - Physician Compare
Medicare program - Medicare providers deemed TRICARE providers
Medicare program - Physician registry use
Medicare program - Shared Savings/Accountable Care Organizations
Medicare program - ACO Exclusivity
Medicare program - MoPath diagnostics
Medicare program - Multiple Procedure Payment Reduction
Medicare program - Quality Measure Development Funding
Medicare program - Care Coordination
Medicare program - Relative Values
Medicare program - Value-based modifier
Medicare program - Cost of care measures
Medicare program - Accreditation of hospitals and imaging suppliers
Medicare program - Enrollment
Medicare program - Molecular diagnostics
Medicare program - Program Integrity
Medicare and Medicaid programs - Tavenner CMS nomination
Medicare and Medicaid programs - Program Integrity
Medicare and Medicaid programs - HIPAA
Medicare and Medicaid programs - ACA implementation issues
Medicaid program - Primary care bonus
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Health & Human Services - Dept of (HHS), Justice - Dept of (DOJ), Medicare Payment Advisory Commission (MedPAC), Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Jennifer |
Meeks |
|
|
|
Mari |
Savickis |
|
|
|
Carol |
Vargo |
|
|
|
George |
Cox |
III |
|
|
Eileen |
Carlson |
|
|
|
Debra |
Cohn |
|
|
|
Kristen |
O'Brien |
|
|
|
Cybil |
Roehrenbeck |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
H.R. 1473, Standard of Care Protection Act of 2013, all provisions
H.R. 1733, Good Samaritan Health Professionals Act of 2013, all provisions
Medical Liability Reform
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |